EUVIMEDEUVIMED entdecken
Leserbrief

Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders

Yu-Hang Cheng, Ke Shang, Chuan Qin, Ming-Hao Dong, Yun-Hui Chu, Ke Huang, Zhi-Cheng Mei, Jun Xiao, Zi-Hao Liang, Yu-Hang Li, Wei Wang, Dai-Shi Tian

New England Journal of Medicine · 03.09.2026 · 395 (9) · 926-929

DOI: 10.1056/nejmc2603114 ↗

Kurz gefasst

Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 03.09.2026. Verfasst von Yu-Hang Cheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Tongji Hospital of Huazhong University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 4 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among 16 patients with refractory neurologic autoimmune disorders, lentiviral CD19 CAR T-cell therapy was associated with manageable side effects, complete B-cell depletion, and preliminary clinical improvement across disease groups.

Autor:innen und Institutionen

  • Tongji Hospital of Huazhong University of Science and Technology, Wuhan, China.
  • Shenzhen Genocury Biotech, Shenzhen, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Cheng, Y. H., Shang, K., Qin, C., Dong, M. H., Chu, Y. H., Huang, K., Mei, Z. C., Xiao, J., Liang, Z. H., Li, Y. H., Wang, W., & Tian, D. S. (2026). Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders. New England Journal of Medicine, 395(9), 926-929. https://doi.org/10.1056/nejmc2603114

Vancouver

Cheng YH, Shang K, Qin C, Dong MH, Chu YH, Huang K, et al. Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders. New England Journal of Medicine. 2026;395(9):926-929. doi:10.1056/nejmc2603114

BibTeX
@article{Cheng2026,
  author = {Cheng, Yu-Hang and Shang, Ke and Qin, Chuan and Dong, Ming-Hao and Chu, Yun-Hui and Huang, Ke and Mei, Zhi-Cheng and Xiao, Jun and Liang, Zi-Hao and Li, Yu-Hang and Wang, Wei and Tian, Dai-Shi},
  title = {Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {395},
  number = {9},
  pages = {926--929},
  doi = {10.1056/nejmc2603114}
}
Kostenlos starten →